Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01143636 · ClinicalTrials.gov registry record · Phase 2

Transcranial Direct Stimulation in Chronic Pelvic Pain

A Phase 2 study, sponsored by Spaulding Rehabilitation Hospital.

Completed
Registry status
Phase 2
Development phase
35
Enrollment target

NCT01143636 is a Phase 2 study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01143636, a Phase 2 study, has completed, sponsored by Spaulding Rehabilitation Hospital.

COMPLETED
Registry status
Phase 2
Development phase
35 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) is effective in reducing pain in subjects with chronic pelvic pain. Our hypothesis is that tDCS will decrease pain significantly when compared to sham stimulation.

Interventions

  • DEVICE Transcranial Direct Current Stimulation

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2010-04
Est. Completion 2013-05
Phase Phase 2

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT01143636

The ClinicalTrials.gov registry entry for NCT01143636 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.

NCT01143636 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01143636 about?

NCT01143636 is a clinical study titled "Transcranial Direct Stimulation in Chronic Pelvic Pain". The purpose of this study is to determine whether transcranial direct current stimulation (tDCS) is effective in reducing pain in subjects with chronic pelvic pain. Our hypothesis is that tDCS will decrease pain significantly when compared to sham stimulation.

What is the current status of trial NCT01143636?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2010-04. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01143636?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01143636?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.